BTA-188 is an orally active and potent inhibitor of human rhinovirus (HRV) and enterovirus (EV) 71; it inhibits HRV-2 replication with an IC50 of 0.8 nM and IC90 of 11 nM, and inhibits enterovirus with an IC50 of 82 nM and IC90 of 109 nM; it is a potential antiviral agent for research on infections caused by Picornaviridae viruses.